57 related articles for article (PubMed ID: 22186408)
21. Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma.
Li H; Bai E; Zhang Y; Jia Z; He S; Fu J
J Immunol Res; 2017; 2017():3970605. PubMed ID: 28168205
[TBL] [Abstract][Full Text] [Related]
22. The multifaceted role of curcumin in cancer prevention and treatment.
Shanmugam MK; Rane G; Kanchi MM; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Tan BK; Kumar AP; Sethi G
Molecules; 2015 Feb; 20(2):2728-69. PubMed ID: 25665066
[TBL] [Abstract][Full Text] [Related]
23. Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer.
Bandyopadhyay D
Front Chem; 2014; 2():113. PubMed ID: 25566531
[TBL] [Abstract][Full Text] [Related]
24. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P; McAndrews DJ; Mohiudddin IQ
BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
[TBL] [Abstract][Full Text] [Related]
25. Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer.
Park HJ; Kim SR; Kim SS; Wee HJ; Bae MK; Ryu MH; Bae SK
Oncotarget; 2014 Jul; 5(13):5087-99. PubMed ID: 24970818
[TBL] [Abstract][Full Text] [Related]
26. A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells.
Mezzanotte L; An N; Mol IM; Löwik CW; Kaijzel EL
PLoS One; 2014; 9(1):e85550. PubMed ID: 24465597
[TBL] [Abstract][Full Text] [Related]
27. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.
Lee WH; Loo CY; Bebawy M; Luk F; Mason RS; Rohanizadeh R
Curr Neuropharmacol; 2013 Jul; 11(4):338-78. PubMed ID: 24381528
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53-Notch1 Signaling Axis Is Involved in Curcumin-Induced Apoptosis of Breast Cancer Cells.
Bae YH; Ryu JH; Park HJ; Kim KR; Wee HJ; Lee OH; Jang HO; Bae MK; Kim KW; Bae SK
Korean J Physiol Pharmacol; 2013 Aug; 17(4):291-7. PubMed ID: 23946688
[TBL] [Abstract][Full Text] [Related]
29. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.
Jiang M; Huang O; Zhang X; Xie Z; Shen A; Liu H; Geng M; Shen K
Molecules; 2013 Jan; 18(1):701-20. PubMed ID: 23299550
[TBL] [Abstract][Full Text] [Related]
30. Diet-induced obesity potentiates the growth of gastric cancer in mice.
Li HJ; Che XM; Zhao W; He SC; Zhang ZL; Chen R
Exp Ther Med; 2012 Oct; 4(4):615-620. PubMed ID: 23170114
[TBL] [Abstract][Full Text] [Related]
31. Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential.
Wang YY; Hung AC; Lo S; Yuan SF
Cancer Lett; 2021 Feb; 498():229-239. PubMed ID: 33152400
[TBL] [Abstract][Full Text] [Related]
32. Cellular and molecular insights into the roles of visfatin in breast cancer cells plasticity programs.
Rajput PK; Sharma JR; Yadav UCS
Life Sci; 2022 Sep; 304():120706. PubMed ID: 35691376
[TBL] [Abstract][Full Text] [Related]
33. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
[TBL] [Abstract][Full Text] [Related]
34. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
Narasimhan M; Ammanamanchi S
Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
[TBL] [Abstract][Full Text] [Related]
35. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
36. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
